Please login to the form below
Central Nervous System
Want to know which agency did which ad? Search using one of the options below.
Agency:
Kane & Finkel
Product:
Diastat
Client:
Elan Pharmaceuticals
Therapy area:
Central Nervous System
Agency:
Kane & Finkel
Product:
Diastat
Client:
Elan Pharmaceuticals
Therapy area:
Central Nervous System
Agency:
Kane & Finkel
Product:
Diastat
Client:
Elan Pharmaceuticals
Therapy area:
Central Nervous System
Agency:
Torre Lazur McCann
Product:
Xeplion
Client:
Janssen-Cilag Ltd
Therapy area:
Central Nervous System
Agency:
Torre Lazur McCann
Product:
Xeplion
Client:
Janssen-Cilag Ltd
Therapy area:
Central Nervous System
Featured jobs
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Senior Strategic Planner, Healthcare Brand Communications, Londo...
-
Competitive Salary
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Senior Account Director or Business Unit Director, Healthcare Ad...
-
C£60, 000 – £70, 000 benefits
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Scientific Engagement Director
-
Salary will be dependant on experience
- Account Director, Training & Medical Communications, London
-
Competitive Salary
- Science Writer – Healthcare Advertising
-
Salary TBC
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
- Multi-Channel Account Managers - Road / Home-office based – Full...
-
Competitive salary
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Medical Writer - Medical Communications
-
£30, 000 - £40, 000 according to skills and experience plus benefits
- Medical Writer, Healthcare Advertising
-
£35 - £45, 000 benefits
Subscribe to our email news alerts
- Roche starts new late-stage trials of Alzheimer’s candidate
- AbbVie builds case for arthritis blockbuster-in-waiting upadacitinib
- Moving annual total (MAT)
- Off BACE: AZ/Lilly drop Alzheimer’s drug lanabecestat
- Key success factor (KSF)
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
- New trial results suggest CAR-T effects are durable in lymphoma
- Evotec says Sanofi deal makes it anti-infectives powerhouse
- Medicen Paris Region appoints new CEO
- How can pharma build bridges with HCPs online?
- NICE set to reject Kyowa Kirin’s Crysvita for XLH
- More impressive data from Bluebird’s gene therapy in thalassemia and sickle cell disease
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Quick links
Infographics
